Patients are relying on Lyft, Uber to travel far distances to medical care

When Lyft driver Tramaine Carr transports seniors and sick patients to hospitals in Atlanta, she feels like both a friend and a social worker.

FDA approves GSK’s JAK inhibitor for rare blood cancer after three-month delay

The FDA approved a new JAK inhibitor, momelotinib, from GSK for adults with the rare bone marrow cancer myelofibrosis who also have anemia. The approval

September 16, 2023

Japan accepts for review GSK’s Nucala application

GSK’s sJNDA for Nucala to treat rhinosinusitis has been accepted for review in Japan. Credit: GSK. The Japanese Ministry of Health, Labour and Welfare (MHLW)

September 4, 2023

Novo Nordisk signs $1.46bn deal to develop molecular glue therapies

Share this article The Novo Nordisk and Neomorph deal is worth approximately $1.46bn in upfront and milestone-based payments across multiple targets. Image Credit: JHVEPhoto /

February 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.